TNF‐α‐mediated reduction in PGC‐1α may impair skeletal muscle function after cigarette smoke exposure
- 26 October 2009
- journal article
- research article
- Published by Wiley in Journal of Cellular Physiology
- Vol. 222 (2) , 320-327
Abstract
Skeletal muscle dysfunction contributes to exercise limitation in COPD. In this study cigarette smoke exposure was hypothesized to increase expression of the inflammatory cytokine, TNF‐α, thereby suppressing PGC‐1α, and hence affecting down stream molecules that regulate oxygen transport and muscle function. Furthermore, we hypothesized that highly vascularized oxidative skeletal muscle would be more susceptible to cigarette smoke than less well‐vascularized glycolytic muscle. To test these hypotheses, mice were exposed to cigarette smoke daily for 8 or 16 weeks, resulting in 157% (8 weeks) and 174% (16 weeks) increases in serum TNF‐α. Separately, TNF‐α administered to C2C12 myoblasts was found to dose‐dependently reduce PGC‐1α mRNA. In the smoke‐exposed mice, PGC‐1α mRNA was decreased, by 48% in soleus and 23% in EDL. The vascular PGC‐1α target molecule, VEGF, was also down‐regulated, but only in the soleus, which exhibited capillary regression and an oxidative to glycolytic fiber type transition. The apoptosis PGC‐1α target genes, atrogin‐1 and MuRF1, were up‐regulated, and to a greater extent in the soleus than EDL. Citrate synthase (soleus—19%, EDL—17%) and β‐hydroxyacyl CoA dehydrogenase (β‐HAD) (soleus—22%, EDL—19%) decreased similarly in both muscle types. There was loss of body and gastrocnemius complex mass, with rapid soleus but not EDL fatigue and diminished exercise endurance. These data suggest that in response to smoke exposure, TNF‐α‐mediated down‐regulation of PGC‐1α may be a key step leading to vascular and myocyte dysfunction, effects that are more evident in oxidative than glycolytic skeletal muscles. J. Cell. Physiol. 222: 320–327, 2010.Keywords
This publication has 37 references indexed in Scilit:
- PGC-1α mediates exercise-induced skeletal muscle VEGF expression in miceAmerican Journal of Physiology-Endocrinology and Metabolism, 2009
- Measuring Mechanical Properties, Including Isotonic Fatigue, of Fast and Slow MLC/mIgf-1 Transgenic Skeletal MuscleAnnals of Biomedical Engineering, 2008
- Peroxisome proliferator-activated receptor expression is reduced in skeletal muscle in COPDEuropean Respiratory Journal, 2007
- PGC-1α protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcriptionProceedings of the National Academy of Sciences, 2006
- Electrophoretic Separation of Human Skeletal Muscle Myosin Heavy Chain Isoforms: The Importance of Reducing AgentsThe Journal of Physiological Sciences, 2006
- Therapeutic prospects to treat skeletal muscle wasting in COPD (chronic obstructive lung disease)Pharmacology & Therapeutics, 2006
- Capillary regression in vascular endothelial growth factor-deficient skeletal musclePhysiological Genomics, 2004
- Transcriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibresNature, 2002
- Chronic Obstructive Pulmonary Disease: Capillarity and Fiber-Type Characteristics of Skeletal MuscleJournal of Cardiopulmonary Rehabilitation, 1998
- Enzymatic heterogeneity of the capillary bed of rat skeletal musclesJournal of Anatomy, 1986